Zobrazeno 1 - 10
of 796
pro vyhledávání: '"K. Watts"'
Autor:
S. Ghorashian, G. Lucchini, R. Richardson, K. Nguyen, C. Terris, J. Yeung, J. Chu, L. Williams, K. Ko, C. Walding, K. Watts, S Inglott, S. Adams, E. Gravett, K. Gilmour, A. Lal, S. Kunaseelan, B. Popova, A. Lopes, Y. Ngai, E. Kokalaki, K. Rao, R. Chiesa, J. Silva, K Mullanfiroze, A. Lazareva, D. Bonney, R Wynn, M. Pule, R. Hough, P. Amrolia
Publikováno v:
HemaSphere, Vol 6, Pp 160-161 (2022)
Externí odkaz:
https://doaj.org/article/b3931ab605064c0397453dc5cd03e343
Autor:
Nathan Bamidele, Han Zhang, Xiaolong Dong, Haoyang Cheng, Nicholas Gaston, Hailey Feinzig, Hanbing Cao, Karen Kelly, Jonathan K. Watts, Jun Xie, Guangping Gao, Erik J. Sontheimer
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Nme2Cas9 has been established as a genome editing platform with compact size, high accuracy, and broad targeting range, including single-AAV-deliverable adenine base editors. Here, we engineer Nme2Cas9 to further increase the activity and ta
Externí odkaz:
https://doaj.org/article/df3d02ad296b4505893c699918456904
The structure, function and reactions of nucleic acids are central to molecular biology and medicine and are crucial for understanding of the ever-expanding range of complex biological processes involved which are central to life. Revised, extended,
Autor:
Minggang Fang, Sara K. Deibler, Pranathi Meda Krishnamurthy, Feng Wang, Paola Rodriguez, Shahid Banday, Ching-Man Virbasius, Miguel Sena-Esteves, Jonathan K. Watts, Michael R. Green
Publikováno v:
Frontiers in Neuroscience, Vol 18 (2024)
Fragile X Syndrome (FXS) is a neurological disorder caused by epigenetic silencing of the FMR1 gene. Reactivation of FMR1 is a potential therapeutic approach for FXS that would correct the root cause of the disease. Here, using a candidate-based shRN
Externí odkaz:
https://doaj.org/article/3a274fd2567945d28c750f6d92ecc94f
Autor:
Hassan H. Fakih, Qi Tang, Ashley Summers, Minwook Shin, Julianna E. Buchwald, Rosemary Gagnon, Vignesh N. Hariharan, Dimas Echeverria, David A. Cooper, Jonathan K. Watts, Anastasia Khvorova, Hanadi F. Sleiman
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 34, Iss , Pp 102080- (2023)
Although an increasing number of small interfering RNA (siRNA) therapies are reaching the market, the challenge of efficient extra-hepatic delivery continues to limit their full therapeutic potential. Drug delivery vehicles and hydrophobic conjugates
Externí odkaz:
https://doaj.org/article/b2737ae9f41849d78fd6f4851c674ed3
Autor:
Atanu Maiti, Adam K. Hedger, Wazo Myint, Vanivilasini Balachandran, Jonathan K. Watts, Celia A. Schiffer, Hiroshi Matsuo
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-10 (2022)
Here, the enzymatic activity of APOBEC3G resulting in conversion of 2′-deoxy-zebularine into a hydration product allowed the authors to capture the transition state, which provides a blueprint for designing a new class of transition state-mimicking
Externí odkaz:
https://doaj.org/article/9b59b40269cb4ef4b61dc593fa6d83f7
Autor:
Shun-Qing Liang, Pengpeng Liu, Jordan L. Smith, Esther Mintzer, Stacy Maitland, Xiaolong Dong, Qiyuan Yang, Jonathan Lee, Cole M. Haynes, Lihua Julie Zhu, Jonathan K. Watts, Erik J. Sontheimer, Scot A. Wolfe, Wen Xue
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-14 (2022)
In vivo assessment of nuclease off-target activity has primarily been indirect or through ChIP-based detection of double-strand break DNA repair factors, which can be cumbersome. Here, the authors show that GUIDE-tag, enables one-step off-target geno
Externí odkaz:
https://doaj.org/article/102ac89073204ae399bf4e3bc3f7fb8c
Autor:
Kye E Poronsky, Katherine E Fleming-Dutra, Nicholas M Mohr, Peter C Hou, Elizabeth Krebs, Sharon H Saydah, Wei Xing, Anusha Krishnadasan, Eva González, David A Talan, Gregory J Moran, Karin F Hoth, Shannon Landers, Ian D Plumb, Kari K Harland, Tamara Pilishvili, Zachary Mankoff, John P Haran, Melissa Briggs-Hagen, Eliezer Santos León, Howard A Smithline, Lilly C Lee, Stephen C Lim, Mark T Steele, David G Beiser, Brett Faine, Utsav Nandi, Walter A Schrading, Brian Chinnock, Anne Chipman, Megan Fuentes, Frank LoVecchio, Bradley Clinansmith, Alysia Horcher, Kelli Wallace, Lisandra Uribe, Kavitha Pathmarajah, Dean M Hashimoto, Monica Bahamon, Michelle St Romain, Efrat Kean, Amy Stubbs, Sara Roy, Gregory Volturo, Amanda Higgins, James Galbraith, James C Crosby, Mary Mulrow, Ryan Gierke, Jennifer L Farrar, Yunmi Chung, Anna Yousaf, Jennifer Onukwube Okaro, Glen R Abedi, Sankan Nyanseor, Christopher K Watts
Publikováno v:
BMJ Open, Vol 13, Iss 2 (2023)
Objectives Although COVID-19 vaccines offer protection against infection and severe disease, there is limited information on the effect of vaccination on prolonged symptoms following COVID-19. Our objective was to determine differences in prevalence
Externí odkaz:
https://doaj.org/article/a13b12e1429245aaa52c10d26627a72c
Publikováno v:
The Journal of Organic Chemistry. 88:5341-5347
Autor:
Feng Wang, Ezequiel Calvo-Roitberg, Julia M Rembetsy-Brown, Minggang Fang, Jacquelyn Sousa, Zachary J Kartje, Pranathi Meda Krishnamurthy, Jonathan Lee, Michael R Green, Athma A Pai, Jonathan K Watts
Publikováno v:
Nucleic Acids Research. 50:12657-12673
Friedreich’s ataxia is an incurable disease caused by frataxin (FXN) protein deficiency, which is mostly induced by GAA repeat expansion in intron 1 of the FXN gene. Here, we identified antisense oligonucleotides (ASOs), complementary to two region